Your browser doesn't support javascript.
loading
Evaluating the development of endometriosis and adenomyosis lesions over time: An ultrasound study of symptomatic women.
Orlov, Sofie; Sladkevicius, Povilas; Jokubkiene, Ligita.
Afiliação
  • Orlov S; Obstetric, Gynecological and Prenatal Ultrasound Research, Department of Clinical Sciences Malmo, Lund University, Malmo, Sweden.
  • Sladkevicius P; Department of Obstetrics and Gynecology, Skane University Hospital, Malmo, Sweden.
  • Jokubkiene L; Department of Obstetrics and Gynecology, Ystad Hospital, Ystad, Sweden.
Acta Obstet Gynecol Scand ; 103(8): 1634-1644, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38687177
ABSTRACT

INTRODUCTION:

There is a gap in knowledge regarding development of endometriosis and adenomyosis lesions visible at transvaginal ultrasound. The objectives were to evaluate if women with symptoms suggestive of endometriosis or adenomyosis but normal ultrasound examination develop endometriosis or adenomyosis lesions visible at ultrasound over time and if alterations of symptoms over time are associated with ultrasound findings at follow-up. MATERIAL AND

METHODS:

This was a prospective cohort study of 100 symptomatic women with normal initial ultrasound examination during 2014-2017 who underwent follow-up ultrasound examination in 2022. Symptoms suggestive of endometriosis were assessed using visual analog scale at both examinations and minimal clinically important difference of 10 mm was considered as a significant alteration. An examiner with expertise in advanced ultrasound examination of endometriosis performed transvaginal ultrasound examinations in accordance with the consensus protocol by the International Deep Endometriosis Analysis group.

RESULTS:

At follow-up ultrasound examination of 100 women, 13 (13% [95% CI 7.1-21.2]) had visible endometriosis or adenomyosis lesions, 8 (8% [95% CI 3.5-15.2]) had endometriosis lesions, and 6 (6% [95% CI 2.2-12.6]) had adenomyosis. At follow-up, women with endometriosis or adenomyosis lesions reported lower intensity of dysmenorrhea and chronic pelvic pain compared to women without lesions (48 mm [IQR 16-79] vs. 73 mm [IQR 46-85] and 45 mm [IQR 26-57] vs. 57 mm [IQR 36-75], p = 0.087 and p = 0.026, respectively). None of the women with endometriosis or adenomyosis lesions reported increased intensity of dysmenorrhea at follow-up, compared to 32/86 women (37%) without lesions (p = 0.008). Increased intensity of chronic pelvic pain tended to be less common in women with lesions compared to those without (3/13 [23%] vs. 35/86 [41%], p = 0.223).

CONCLUSIONS:

Our findings suggest that in symptomatic women, endometriosis and adenomyosis lesions visible at ultrasound may develop over time. However, majority of women remain having normal ultrasound examinations despite symptoms. Exacerbation of dysmenorrhea or chronic pelvic pain during follow-up was not associated with the development of endometriosis or adenomyosis lesions visible at ultrasound, suggesting that even women with less severe symptoms might benefit from a follow-up ultrasound when indicated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ultrassonografia / Endometriose / Adenomiose Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ultrassonografia / Endometriose / Adenomiose Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article